December 7, 2015 : DCMS #270

DISASTERS AVERTED — Near Miss Case Studies

With Diabetes, Symptoms Are Not Always as Expected

HOMERUN SLIDES — Great Clinical Presentation Highlights

The Present and Future of Insulin Therapy Part 19

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #1: Classification of Diabetes Mellitus and Other Categories of Glucose Intolerance Part 1 of 6

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Dr. Richard Bergman, Part 2 – Insulin Resistance Risk Factors

MOST POPULAR ARTICLES OF THE MONTH

#1 Breastfeeding after Gestational Diabetes Mellitus
#2 Nordic Food Associated with Lowering Risk of Type 2 Diabetes
#3 Pleiotropic Effects of Metformin To Be Studied

Steve and I have been providing you with this newsletter for the past 16 years. We have added a great staff to turn out what we consider to be the best source of diabetes information available. During these 16 years we have been able to see what you, our readers, like best each and every week. Last week’s video interview with Dr. Richard Bergman was one of the most watched videos ever, and this week we have part 2 of that series. Click here for part 2, and if you did not watch part 1, I am sure you will want to go back and check that out as well.

Most times the diagnosis of diabetes is pretty simple but in this week’s Disaster Averted, we see how the symptoms don’t always match the diagnosis. See if you can figure out what is going on.

Your partner in diabetes care,
Dave Joffe
Editor-in-chief

Male, 72 years of age, type 2, insulin requiring diabetes, also taking SGLT-2. Annual physical. No urinary complaints during the visit. Received annual lab work end of work day, glucose elevated much higher than he reports. WBC elevated, 1200, no urine culture, but U/A did show cloudy, leukocyte esterase 2+, wbc >60 H, bacteria many (>50) H, RBC 3-10, H.

In this week’s Homerun Slides, the philosophy for the reduced need for insulin in type 2 patients and the potential benefits of combining GLP-1-based therapies with insulin.

A critical requirement for orderly epidemiologic, genetic and clinical research, and indeed for the management of diabetes mellitus and other forms of glucose intolerance is an appropriate classification system. Furthermore, a hallmark in the process of understanding the etiology of a disease and studying its natural history is the ability to identify and differentiate its various forms and place them into a rational etiopathologic framework.

Diabetes in Control publisher Steve Freed and Dr. Richard Bergman discuss who is insulin resistant and the risk factors for insulin resistance. Dr. Richard Bergman is the founder and director of the Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes. Dr. Bergman was awarded the Albert Renold Award at the American Diabetes Association’s 75th Scientific Sessions in Boston for a career distinguished by outstanding achievements in the training and mentorship of diabetes research scientists, and in the facilitation of diabetes research.

Longer duration of breastfeeding showed correlation with reduction of type 2 risk.

Diet containing foods high in antioxidants found to reduce risk of stroke.

Evidence shows cardio-protective ability beyond glucose-lowering mechanism of action.